This multi-site study will examine patients with post-traumatic epilepsy and post-traumatic psychogenic non-epileptic seizures (PNES), and will compare these patients to those with traumatic brain injury (TBI) who do not have seizures using functional neuroimaging.
The BELLE study is investigating whether Brivaracetam (Briviact®) given intravenously (into the vein) is safe for children and what it does in the body.
In a first-in-humans pilot study, researchers identified a sentinel area of the brain that may give an early warning before clinical seizure manifestations appear.
$150,000 Commitment in Support of 20th Annual Benefit and ‘Taking Flight’ Research Award
This pilot randomized, parallel-group, controlled trial comparing the GoToSleep program and controls on change in Insomnia Severity Index (ISI) from baseline to week 8 in adults with epilepsy and moderate-to-severe insomnia.
New guidelines highlight the evidence supporting the use of certain anti-epileptic drugs for reducing the frequency of seizures in new-onset focal epilepsy and treatment-resistant epilepsy.
Genetics
Scientists report developing high-tech tools to uncover the genetic cause of early infantile epileptic encephalopathy (EIEE).
The underlying pathogenesis of new-onset seizures or epilepsy in recipients of transplantation needs to be further elucidated. In addition, more information is required from prospective studies and research focusing on therapeutic strategies.
